Get Permission Impana BD, Seethalakshmi S, and Raghavendran R: A rare and challenging case of pineal gland tumor – A case report


Introduction

The pineal glands can show varied lesions ranging from pineal cysts, aneurysms, cavernous vascular malformations, arteriovenous malformations and tumors. Pineal region tumors account for less than 1% of intracranial tumors and are very rare in occurrence.1 Pineal region tumors are classified as germ cell tumors, pineal parenchymal tumors and those derived from adjacent anatomical structures. Germinoma is the most common pineal tumor in Asian population.2

Pineal parenchymal tumors (PPT) constitute 15 to 30% of pineal region tumors.3 The tumors range from well differentiated neoplasm with presence of pineocytomatous rosettes to poorly differentiated malignant embryonal neoplasm occurring within first two decades of life. We present a case of intermediate differentiation with variable biological behaviour and may be classified according to WHO as grade II or III.

Case History

A 54-year-old female presented with history of skid and fall from bike. Magnetic resonance imaging (MRI) was done which showed a lesion in the pineal region but the patient was lost for follow up. Nine months later patient presented with bilateral watering of eyes and repeat MRI showed pineal region tumor for which surgery was advised and total excision was performed. The specimen was received in the department of histopathology of our hospital.

Figure 1

MRI brain showing pineal region tumor.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a62ad913-d798-4951-ac6a-982aea683d7dimage1.jpeg

Grossly nodular, dull white soft tissue 3 x 2 cm with few tiny fragmented bits of 0.2 x 0.2 cm was received. Cut Section was pale white and was all embedded.

The histopathology showed a well circumscribed vaguely lobulated tumor having large round nucleus, mild to moderate atypia separated by vascular channels. Also, tumor cells in sheets with background of fibrillary matrix was noted. These cells had perinuclear clearing. Few bi and multinucleated cells was noted. Focal areas showed atypia with hyperchromatic elongated nucleus. 3 to 5 mitotic figures / 10 hpf was seen. Peripheral normal brain tissue was noted.

Figure 2

Low power view of a well circumscribed lobulated tumor in pineal region. H&E stain 200x

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a62ad913-d798-4951-ac6a-982aea683d7dimage2.jpeg
Figure 3

Lobulated tumor having intermediate to large round nucleus separated by vascular channels. H&E stain 400x

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a62ad913-d798-4951-ac6a-982aea683d7dimage3.jpeg
Figure 4

Neurocytoma-like appearance in a pineal parenchymal tumour of intermediate differentiation. Tumour with moderate cellularity and round nuclei harbouring salt-and-pepper chromatin. H&E stain 400x

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a62ad913-d798-4951-ac6a-982aea683d7dimage4.jpeg

Immunohistochemistry (IHC) was carried out with the following markers:

Table 1

IHC markersand result.

Marker

Result

EMA

Negative

GFAP

Negative

S100

Positive in few large cells and few small cells

Olig-2

Negative

Synaptophysin

Positive

CD56

Positive

Chromogranin A

Positive (dot like)

Ki67

3 to 5%

The IHC results was consistent with tumor of pineal origin. Correlating with H and E picture final diagnosis of pineal parenchymal tumor of intermediate differentiation, grade II was given. Adjuvant radio / chemotherapy was not given. The patient is on follow up and is recurrence free two years post surgery.

Discussion

The pineal gland got its name as “third eye” due to its pine cone shape and is situated in the epithalamus and its function is to modulate circadian rhythm through the production of melatonin.4 Pineal gland parenchymal tumors include pineocytoma grade I, pineal parenchymal tumor of uncertain differentiation (PPTID) grade II or grade III, pineoblastoma grade IV, papillary tumor of the pineal region grade II or III and new addition in this group is Desmoplastic myxoid tumor of the pineal region, SMARCB1-mutant according to fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021.5 All pineal tumors need surgery to obtain a tissue diagnosis and hence to reduce the symptoms caused due to impaired cerebrospinal flow from third ventricle into the cerebral aqueduct.6 PPTIDs account for 45% of all pineal parenchymal tumors and the mean age at diagnosis of PPTID is around 41 years, although all ages can be affected.7  It was first described by Schild et al in 1993.8 

Patients usually present with signs of increased intracranial pressure like headache, vomiting secondary to obstructive hydrocephalus. Other symptoms are ataxia, Parinaud syndrome, or diplopia.9

On microscopy PPTID can exhibit two architectural patterns – Diffuse or lobulated with vessels delineating the lobules. The PPTIDs are moderately to highly cellular tumors with neoplastic cells displaying round nuclei, salt and pepper chromatin showing mild to moderate atypia. The cytoplasm of the cells is easily distinguished compared to pineoblastoma. The pleomorphic variant shows bizarre ganglioid cells with single or multiple atypical nuclei and abundant cytoplasm. The mitotic count is variable and range from 3.5 to 16.1%.10

According to study done by Jouvet et al, PPT with intermediate differentiation can be divided in two grades: Grade II showed lobulated, transitional, and diffuse PPT with strong immunolabeling for neurofilament and less than 6 mitoses and grade III was a lobulated and diffuse PPT with less than or more than 6 mitoses but without immunostaining for neurofilament.11

In the same study, four different morphological subtypes of PPTID were identified by Jouvet et al.

  1. Lobular arrangement of cells with an endocrine vascularity.

  2. Diffuse proliferation mimicking oligodendroglioma or neurocytoma

  3. Lobulated and/or diffuse areas associated with other areas containing pineocytomatous rosettes corresponded to transitional forms.

  4. Distinctly biphasic pattern including areas of typical pineocytoma and pineoblastoma.

Our case also showed vaguely lobulated and also focally sheets of tumor cells with round nucleus displaying salt and pepper chromatin. Intervening vascular channels dividing into lobules was seen. The mitotic index was low.

Immunohistochemistry of PPTID shows synaptophysin positivity, variable positivity for Neurofilament and chromogranin. S100 is expressed in ganglion cells of pleomorphic variant.

PPTIDs have better prognosis due to its localized presentation. They have a potential for local recurrence and craniospinal dissemination. Histologic grade, PPTID subtype, extent of resection, and neuraxis spread at diagnosis are important factors for outcome in PPT.12 The main treatment option is microsurgery and is the standard modality, alternatives include stereotactic radiosurgery. For selected cases, adjuvant treatment to surgery also holds promise.

Conclusion

PPTID is of intermediate differentiation between pineocytoma and pineoblastoma. The biological behavior is variable and definite histological grading criteria is not defined in WHO. The extent of resection, histologic grade and craniospinal dissemination at presentation are important factors for outcome of pineal parenchymal tumors.

Conflict of Interest

None.

Source of Funding

None.

References

1 

G Favero F Bonomini R Rezzani Pineal Gland Tumors: A ReviewCancers2021137154710.3390/cancers13071547

2 

K Nomura Epidemiology of germ cell tumors in Asia of pineal region tumorJ Neurooncol2001543211710.1023/a:1012771204732

3 

F Cuccia G Mortellaro D Cespuglio V Valenti G De Gregorio E Quartuccio A case report of adult pineoblastoma occurring in a pregnant womanAnticancer Res201939526273110.21873/anticanres.13386

4 

MM Macchi JN Bruce Human pineal physiology and functional significance of melatoninFront Neuroendocrinol2004253-417795

5 

DN Louis A Perry P Wesseling DJ Brat IA Cree D Figarella-Branger The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro Oncol202123812315110.1093/neuonc/noab106

6 

VR Deshmukh KA Smith HL Rekate S Coons RF Spetzler Diagnosis and management of pineocytomasNeurosurgery200455234955

7 

DN Louis H Ohgaki OD Wiestler WK Cavenee WHO Classification of Tumours of the Central Nervous System, Revised. 4th edn.International Agency for Research on Cancer PressLyon201616980

8 

KW Min BW Scheithauer SC Bauserman Pineal parenchymal tumors: an ultrastructural study with prognostic implicationsUltrastruct Pathol1994181-26985

9 

F Fauchon A Jouvet P Paquis Parenchymal pineal tumors: a clinicopathological study of 76 casesInt J Radiat Oncol Biol Phys200046495968

10 

T Ito H Kanno K Sato M Oikawa Y Ozaki H Nakamura Clinicopathologic study of pineal parenchymal tumors of intermediate differentiationWorld Neurosurg2014815- 67839

11 

A Jouvet G Saint-Pierre F Fauchon K Privat E Bouffet M M Ruchoux Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 casesBrain Pathol20001014960

12 

DR Raleigh DA Solomon SA Lloyd A Lazar MA Garcia PK Sneed Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcomeNeuro Oncol20171917888



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 10-06-2023

Accepted : 04-08-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jdpo.2023.043


Article Metrics






Article Access statistics

Viewed: 741

PDF Downloaded: 1289



Medical Abbreviation List